Study of a Booster Dose of a Tetravalent Dengue Vaccine in Subjects Who Previously Completed the 3-dose Schedule
Clinical trial NCT02623725 · COMPLETED
Trial details
- NCT number
- NCT02623725
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-14
- Primary completion
- 2016-11-23
- Enrollment
- 251
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.